SI1513861T1 - Novi estri etonogestrela - Google Patents

Novi estri etonogestrela

Info

Publication number
SI1513861T1
SI1513861T1 SI200330679T SI200330679T SI1513861T1 SI 1513861 T1 SI1513861 T1 SI 1513861T1 SI 200330679 T SI200330679 T SI 200330679T SI 200330679 T SI200330679 T SI 200330679T SI 1513861 T1 SI1513861 T1 SI 1513861T1
Authority
SI
Slovenia
Prior art keywords
new
etonogestrel esters
esters
new etonogestrel
etonogestrel
Prior art date
Application number
SI200330679T
Other languages
English (en)
Inventor
Nijs Henrik De
Der Voort Hendrikus Adrianus Antonius Van
Dirk Leysen
Arij Jan Grootenhuis
Original Assignee
Organon Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Organon Nv filed Critical Organon Nv
Publication of SI1513861T1 publication Critical patent/SI1513861T1/sl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051—Estrane derivatives
    • C07J1/0081—Substituted in position 17 alfa and 17 beta
    • C07J1/0088—Substituted in position 17 alfa and 17 beta the substituent in position 17 alfa being an unsaturated hydrocarbon group
    • C07J1/0096—Alkynyl derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/16—Masculine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/34—Gestagens
SI200330679T 2002-05-30 2003-05-22 Novi estri etonogestrela SI1513861T1 (sl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP02077119 2002-05-30
EP03735713A EP1513861B1 (en) 2002-05-30 2003-05-22 New etonogestrel esters
PCT/EP2003/050187 WO2003102012A2 (en) 2002-05-30 2003-05-22 New etonogestrel esters

Publications (1)

Publication Number Publication Date
SI1513861T1 true SI1513861T1 (sl) 2007-06-30

Family

ID=29595014

Family Applications (1)

Application Number Title Priority Date Filing Date
SI200330679T SI1513861T1 (sl) 2002-05-30 2003-05-22 Novi estri etonogestrela

Country Status (31)

Country Link
US (1) US7323454B2 (sl)
EP (1) EP1513861B1 (sl)
JP (1) JP4716726B2 (sl)
KR (1) KR20050009723A (sl)
CN (2) CN101100480A (sl)
AR (1) AR040130A1 (sl)
AT (1) ATE349458T1 (sl)
AU (1) AU2003238081B2 (sl)
BR (1) BR0311254A (sl)
CA (1) CA2487722C (sl)
CO (1) CO5631449A2 (sl)
DE (1) DE60310714T2 (sl)
DK (1) DK1513861T3 (sl)
ES (1) ES2277085T3 (sl)
HK (1) HK1072609A1 (sl)
HR (1) HRP20041101A2 (sl)
IL (1) IL165087A0 (sl)
IS (1) IS2421B (sl)
MX (1) MXPA04011797A (sl)
NO (1) NO20044898L (sl)
NZ (1) NZ536619A (sl)
PE (1) PE20040068A1 (sl)
PL (1) PL373855A1 (sl)
PT (1) PT1513861E (sl)
RS (1) RS97604A (sl)
RU (1) RU2325910C2 (sl)
SI (1) SI1513861T1 (sl)
TW (1) TW200403065A (sl)
UA (1) UA80126C2 (sl)
WO (1) WO2003102012A2 (sl)
ZA (1) ZA200410410B (sl)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW200400041A (en) * 2002-05-30 2004-01-01 Akzo Nobel Nv Use of new etonogestrel esters
WO2007011708A2 (en) 2005-07-15 2007-01-25 Micell Technologies, Inc. Stent with polymer coating containing amorphous rapamycin
KR101406415B1 (ko) 2005-07-15 2014-06-19 미셀 테크놀로지즈, 인코포레이티드 제어된 형태의 약물 분말을 함유하는 중합체 코팅
AU2007243268B2 (en) 2006-04-26 2013-06-13 Micell Technologies, Inc. Coatings containing multiple drugs
US11426494B2 (en) 2007-01-08 2022-08-30 MT Acquisition Holdings LLC Stents having biodegradable layers
JP5603598B2 (ja) 2007-01-08 2014-10-08 ミセル テクノロジーズ、インコーポレイテッド 生物分解層を有するステント
BRPI0910969B8 (pt) 2008-04-17 2021-06-22 Micell Technologies Inc dispositivo
JP2011528275A (ja) 2008-07-17 2011-11-17 ミセル テクノロジーズ，インク． 薬物送達医療デバイス
US20100239635A1 (en) 2009-03-23 2010-09-23 Micell Technologies, Inc. Drug delivery medical device
JP2012522589A (ja) 2009-04-01 2012-09-27 ミシェル テクノロジーズ，インコーポレイテッド 被覆ステント
EP3366326A1 (en) 2009-04-17 2018-08-29 Micell Technologies, Inc. Stents having controlled elution
EP2453834A4 (en) 2009-07-16 2014-04-16 Micell Technologies Inc MEDICAL DEVICE DISPENSING MEDICINE
EP2531140B1 (en) 2010-02-02 2017-11-01 Micell Technologies, Inc. Stent and stent delivery system with improved deliverability
EP2560576B1 (en) 2010-04-22 2018-07-18 Micell Technologies, Inc. Stents and other devices having extracellular matrix coating
WO2012009684A2 (en) 2010-07-16 2012-01-19 Micell Technologies, Inc. Drug delivery medical device
WO2013012689A1 (en) 2011-07-15 2013-01-24 Micell Technologies, Inc. Drug delivery medical device
US10188772B2 (en) 2011-10-18 2019-01-29 Micell Technologies, Inc. Drug delivery medical device
EP2967803B1 (en) 2013-03-12 2023-12-27 Micell Technologies, Inc. Bioabsorbable biomedical implants
KR102079613B1 (ko) 2013-05-15 2020-02-20 미셀 테크놀로지즈, 인코포레이티드 생흡수성 생체의학적 임플란트
RU2595818C1 (ru) * 2015-05-25 2016-08-27 Федеральное государственное бюджетное научное учреждение "Научный центр проблем здоровья семьи и репродукции человека" Способ комплексного лечения дисфункции яичников при применении гормонального контрацептива имплантата "импланона"
CN111057120B (zh) * 2019-12-27 2021-04-27 苏州翔实医药发展有限公司 一种依托孕烯衍生物a及其制备方法和用途

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1013284B (de) 1956-03-22 1957-08-08 Schering Ag Verfahren zur Einfuehrung der Reste wenig reaktionsfaehiger Carbonsaeuren, insbesondere des ª‰-Cyclopentyl-propionylrestes, in die 17ª‡-staendige Oxygruppe solcher Steroide, die am Kohlenstoffatom 17 neben der Oxygruppe eine Acetylgruppe tragen
GB845442A (en) 1956-03-22 1960-08-24 Schering Ag Manufacture of steroid compounds
GB8313921D0 (en) * 1983-05-19 1983-06-22 World Health Org Contraceptive compositions
DE4227989A1 (de) 1992-08-21 1994-06-09 Schering Ag Mittel zur transdermalen Applikation enthaltend 3-Keto-desogestrel
DE4240806A1 (de) 1992-12-01 1994-06-09 Schering Ag Mittel zur transdermalen Applikation enthaltend 14alpha,17alpha-Ethanoestra-1,3,5(10)-trien-3,17beta-diol
JPH07101884A (ja) 1993-10-01 1995-04-18 Sanei Gen F F I Inc 水溶性ヘミセルロースを含有する製剤
AU692504B2 (en) 1993-12-27 1998-06-11 Akzo Nobel N.V. Percutaneously absorbable preparation
DE19613698A1 (de) 1995-07-17 1997-01-23 Schering Ag Mittel zur transdermalen Applikation enthaltend Ester des 13-Ethyl-17ß-hydroxy-11-methylen-18,19-dinor-17alpha-pregn-4-en-20-yn-3-ons
WO1997003709A1 (de) * 1995-07-17 1997-02-06 Schering Aktiengesellschaft Mittel zur transdermalen applikation enthaltend ester des 3-ketodegestrel
AU4513099A (en) 1998-06-19 2000-01-10 Akzo Nobel N.V. Cycloalkyl-carboxylic acid esters of 7.alpha.methyl-estr-4-en-3-one 17.beta.-ol (19-nor 7.alpha.-methyltestosterone)
EP1087986B1 (en) 1998-06-19 2002-04-10 Akzo Nobel N.V. 7.alpha.-methyl 19-nortestosterone undecanoate with androgenic activity
US6180682B1 (en) 1999-01-26 2001-01-30 Virgil A. Place Buccal drug delivery system for use in male contraception
TW200400041A (en) * 2002-05-30 2004-01-01 Akzo Nobel Nv Use of new etonogestrel esters

Also Published As

Publication number Publication date
CA2487722A1 (en) 2003-12-11
RU2325910C2 (ru) 2008-06-10
IL165087A0 (en) 2005-12-18
WO2003102012A9 (en) 2005-01-13
MXPA04011797A (es) 2005-03-31
JP2005532350A (ja) 2005-10-27
DK1513861T3 (da) 2007-04-10
AR040130A1 (es) 2005-03-16
HRP20041101A2 (en) 2004-12-31
CO5631449A2 (es) 2006-04-28
EP1513861A2 (en) 2005-03-16
AU2003238081A1 (en) 2003-12-19
TW200403065A (en) 2004-03-01
PL373855A1 (en) 2005-09-19
CA2487722C (en) 2011-07-19
DE60310714T2 (de) 2007-10-11
AU2003238081B2 (en) 2008-09-18
WO2003102012A2 (en) 2003-12-11
ZA200410410B (en) 2006-02-22
NO20044898L (no) 2005-02-25
UA80126C2 (en) 2007-08-27
JP4716726B2 (ja) 2011-07-06
RU2004138807A (ru) 2005-05-27
IS2421B (is) 2008-10-15
ES2277085T3 (es) 2007-07-01
PE20040068A1 (es) 2004-02-18
BR0311254A (pt) 2005-03-15
US20050222113A1 (en) 2005-10-06
ATE349458T1 (de) 2007-01-15
HK1072609A1 (en) 2005-09-02
NZ536619A (en) 2007-09-28
US7323454B2 (en) 2008-01-29
DE60310714D1 (de) 2007-02-08
EP1513861B1 (en) 2006-12-27
CN1314701C (zh) 2007-05-09
RS97604A (en) 2006-10-27
KR20050009723A (ko) 2005-01-25
CN101100480A (zh) 2008-01-09
IS7528A (is) 2004-11-15
WO2003102012A3 (en) 2004-04-22
CN1692122A (zh) 2005-11-02
PT1513861E (pt) 2007-03-30

Similar Documents

Publication Publication Date Title
HK1072609A1 (en) New etonogestrel esters
AU2003249738A8 (en) Ostoscope
AU2003297193A8 (en) Meta-web
AU2003252028A8 (en) Heterodiamondoids
AU2003279495A8 (en) Alert-modeling
GB2400797B (en) Shelving
HK1072568A1 (en) Use of new etonogestrel esters
AU2002367810A8 (en) Bis-transition-metal-chelate-probes
AU2003264900A8 (en) Cast-cutter
AU2003262681A8 (en) Hemo-aide
GB0310123D0 (en) Airfreshener combined luminair
AU2002341221A8 (en) Honey-brandy
AU2003253735A8 (en) Vacuolins
GB0215011D0 (en) Easy squeezy
AU2327P (en) Archnah Arctotis fastuosa
AU2326P (en) Gavol Gazania rigens
PL113111U1 (en) Shelving
GB0214885D0 (en) Medicament
GB0211377D0 (en) Medicament
GB0227620D0 (en) Easy Klik
GB0210565D0 (en) Concept three
AU149787S (en) Pedestal
GB0204882D0 (en) Pedestal
GB0210564D0 (en) Concept four
AU148728S (en) Tablet